Undzys Elijus - Drug Delivery and Formulation Group, Ontario Institute for Cancer Research

基本信息

浏览量：9

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 37 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Abstract 1869: The AI-powered KisoSeek™ platform identifies functional anti-TROP2 heavy-chain antibodies with potent anti-cancer activity

Sophie E. Cousineau,Amit Subedi,Richard Wargachuk, Juliana The, Xiaowei Wang,Wenyang Hou, Amogh Nair, Wansu Qiu,Alex Zhou,Tiffany Cheng, Morteza Babaie, Benyamin Gojogh,Marinieve Montero,Hiba Zahreddine,Elijus Undzys,Lucy Lai,Gordon Ngan,Luis Da Cruz, David Young

Cancer Researchno. 6_Supplement (2024): 1869-1869

引用0浏览0引用

Abstract 5661: Pre-clinical development of a dopamine receptor 2, PD-1, and CD47 trispecific antibody for the treatment of solid tumors

Shugang Yao,Hiba Ahmad Zahreddine,Dominic Hou,Elijus Undzys,Liying Gong,Richard Wargachuk,Xiaowei Wang,Alex Zhou,Lucy Lai, Luis A. Da Cruz, David Young

Cancer Researchno. 7_Supplement (2023): 5661-5661

引用0浏览0引用

Discovery of OICR12694: A Novel, Potent, Selective, and Orally Biovailable BCL6 BTB Inhibitor

Ahmed Mamai,Anh M. Chau,Brian J. Wilson,Iain D. Watson,Babu B. Joseph,Pandiaraju R. Subramanian, Monzur M. Morshed, Justin A. Morin, Michael A. Prakesh,Tianbao Lu,Pete Connolly,Douglas A. Kuntz,Neil C. Pomroy,Gennady Poda,Kong Nguyen,Richard Marcellus,Graig Strathdee,Brigitte Theriault,Ratheesh Subramaniam,Mohammed Mohammed,Ayome Abibi,Manuel Chan,Jeffrey Winston,Taira Kiyota,Elijus Undzys,Ahmed Aman,Nigel Austin, Marc Du Jardin,Kathryn Packman, Ulrike Phillippar, Riccardo Attar,James Edwards,Jeff O'Meara,David E. Uehling,Rima Al-awar,Gilbert G. Prive,Methvin B. Isaac

ACS medicinal chemistry letters（2023）

引用1浏览0WOS引用

Functional characterization of KJ-103, a novel therapeutic anti-TROP2 heavy chain- only antibody

Shugang Yao,Hiba Zahreddine,Amit Subedi,Liying Gong, Amogh Nair,Alex Zhou,Tiffany Cheng,Elijus Undzys,Dominic Hou,Lucy Lai, Luis A. Da Cruz, David Young

CANCER RESEARCHno. 7 (2023)

引用0浏览0引用

Abstract 2931: Functional Characterization of KJ-103, a Novel Therapeutic Anti-Trop2 Heavy Chain-Only Antibody

Shugang Yao,Hiba Zahreddine,Amit Subedi,Liying Gong, Amogh Nair,Alex Zhou,Tiffany Cheng,Elijus Undzys,Dominic Hou,Lucy Lai, Luis A. Da Cruz, David Young

Cancer researchno. 7_Supplement (2023): 2931-2931

引用0浏览0引用

Kisobody: Development And Pre-Clinical Assessment Of A Novel Multispecific Antibody Platform

Richard Wargachuk,Dominic Hou,Claire Bonfils,Nicolas Morin,Shugang Yao,Milica Krstic,Yun Cui,Jacynthe L. Toulouse,Donald Gagne,Elijus Undzys,Alex Zhou,Emily Chen, Ashwani Gupta,Luis Dacruz,David Young

CANCER RESEARCH（2021）

引用0浏览0引用

Abstract P200: Pre-clinical development of a dopamine receptor 2, PD-1 and CD47 trispecific antibody for treatment of small cell lung cancer

Shugang Yao,Yun Cui,Anna Kazanats,Liying Gong,Claire Bonfils,Dominic Hou,Emily Chen,Elijus Undzys,Jacynthe Toulouse,Milica Krstic,Hiba Zahreddine,Israel Matos,Alex Zhou,Aniel Moya-Torres,Richard Wargachuk,Carl Gay,Lauren Byers,Gordon Ngan,Luis da Cruz, David Young

Poster Presentations - Proffered Abstracts (2021)

引用0浏览0引用

Abstract 7: Discovery of OICR-10268: A Potent and Selective BCL6 Inhibitor

Lain D. Watson,Methvin Isaac,Brian Wilson,Anh Chau, Justin Morin,Pandiaraju Subramanian,Ahmed Mamai,Babu Joseph,Michael Prakesch,David Uehling,Ayome Abibi,Richard Marcellus,Craig Strathdee,Ratheesh Subramaniam,Brigitte Theriault,Jeffrey Winston,Manuel Chan,Carly Griffin, Herman Cheung,Taira Kiyota,Elijus Undzys,Ahmed Aman,Gennady Poda, Doug Kuntz,Neil C. Pomroy,Gil G. Prive,Rima Al-awar

Cancer Chemistry（2019）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn